If you have been reading about nitric oxide system and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-11-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
Lyophilized peptide powder is generally stored at minus twenty degrees Celsius or lower and kept away from light and moisture. Under these conditions degradation is slow, and sealed vials remain stable for extended periods. Once dissolved, the material is less stable, particularly in aqueous buffers near neutral pH, where hydrolysis and oxidation proceed faster. Solutions are usually kept cold and used within days to weeks. Repeated freeze-thaw cycles are avoided because they encourage aggregation.
Identity and purity are established using reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and yields a percentage purity. Mass spectrometry, typically with electrospray ionization, confirms the molecular mass against the expected value. Amino acid analysis or peptide mapping provides additional sequence confirmation. These methods are complementary, since chromatography measures how much material is present while mass spectrometry verifies what that material is. A certificate of analysis normally reports both.
Analytical results depend on the column, gradient, and detector wavelength chosen by the laboratory, so purity values from different sources are not always directly comparable. Water content, counterion form, and residual trifluoroacetate affect both mass and purity calculations. Microbiological and endotoxin testing are separate from chemical purity and are not covered by a standard chromatographic run. Buyers evaluating a material typically request the full method description rather than a single purity figure.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
== Finite elasticity == The elastic behavior of objects that undergo finite deformations has been described using a number of models, such as Cauchy elastic material models, Hypoelastic material models, and Hyperelastic material models. The deformation gradient (F) is the primary deformation measure used in finite strain theory.
== Construction == The tablets were originally made of wood and wax, though only the wood was preserved and recoverable. A typical tablet would have been made of a thin piece of wood, 15–25 cm wide, with a rectangular depression carved into the centre. Warm beeswax, blackened by the addition of atramentum, would then be poured into the centre depression and allowed to cool. Once the wax had set, a metal stylus would be used to scratch letters into the wax, showing a lighter colour against the darker wax. These wax tablets could be recycled, in that the tablet could be heated (to approximately 50 °C), allowing the wax to soften and reform a smooth writing surface. The tablets were likely made from wood recycled from barrel staves, and often were made in diptych style, where two tablets were loosely linked and could fold together to close, like a book with only two pages, protecting the soft wax on the inside. Evidence suggests the tablets were made from staves due to the discovery of several staves and glazing objects at the site alongside the tablets. These staves are of the same type of wood (silver fir) as the tablets. However there were two ink leaf tablets inscribed with a pen that were discovered at the same site.
Selenium deficiency occurs when an organism lacks the required levels of selenium, a critical nutrient in many species. Deficiency, although relatively rare in healthy well-nourished individuals, can have significant negative results, affecting the health of the heart and the nervous system; contributing to depression, anxiety, and dementia; and interfering with reproduction and gestation.
Sources: en.wikipedia.org
Chaplain, University of Sunderland. For services to Higher Education. Dr Catherine Marian Hubbert. Macmillan General Practitioner and Founder, Woodlands Hospice Charitable Trust. For services to Palliative Care. Antony Jasper Hudgell. Co-Founder, Tony Hudgell Foundation. For services to the Prevention of Child Abuse. Karen Humphries. Assessor and Duke of Edinburgh Award Manager, Nunnery Wood High School, Worcester. For services to Young People. Graham Walter Hundley. Emergency Response Volunteer, Cumbria. For voluntary service to the British Red Cross. Elaine Hutchings. For services to the community in Lichfield, Staffordshire during Covid-19. Lena Moira Hutchinson. For voluntary services to the community in Larne, County Antrim. William David Hutton. Founder, Campsie Accordion and Fiddle Club. For services to Music and to the community in Dunbartonshire. Robert Alan John Illman. For services to Mountain Rescue in Dartmoor, Devon. Richard Stansfield Isaac. Community and Sustainability Manager, Northern Trains. For services to Inclusion in the Rail Industry. Clive Herbert Jackson. For services to the community in York. Christopher Angus Jamieson. Special Inspector, British Transport Police (Scotland). For services to Policing. Patricia Carol Jarman. For services to the community in Stalybridge, Metropolitan Borough of Tameside. Michael George Jaynes. Akela, 1st Hatherley Scouts, Cheltenham. For services to Young People and to the community in Cheltenham, Gloucestershire. Hilary Mary Jenkins. For services to the community in Wiltshire, particularly during Covid-19.
== Application == One application of FAIMS is as an additional separation step between the liquid chromatography separation and mass spectrometric analysis in liquid chromatography–mass spectrometry (LC-MS) as used in proteomic studies. It allows for online fractionation of the analyte components to improve detection of peptides in complex samples. LC-MS uses the mass to charge ratio of peptide ions to analyse samples and the resulting spectra are compared to spectral reference libraries. FAIMS can be used to filter out "chemical noise", i.e. compounds whose spectra would interfere with the spectra of the desired compound, either by overlapping with the desired compound's spectra or adding additional peaks to the spectra. It can be used to filter out interfering ions and simultaneously select peptides with charge states that are optimal for analysis. A further advantage of this technique is that it can be used to select for peptide ions that are of low abundance in the sample. Such low abundance ions are often not analysed because of the limitations of the duty cycles of the mass spectrometers. By selectively removing the more abundant ions FAIMS can assist in distinguishing between ions with similar mass to charge ratios and can prevent a more abundant ion from masking the presence of a less abundant ion.
Cannabis users demonstrated increased activity in task-related brain regions, consistent with reduced processing efficiency. A reduced quality of life is associated with heavy cannabis use, although the relationship is inconsistent and weaker than for tobacco and other substances. The direction of cause and effect, however, is unclear. The long-term effects of cannabis are not clear. There are concerns surrounding memory and cognition problems, risk of addiction, and the risk of schizophrenia in young people.
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.